## Core Concept
Alpha-fetoprotein (AFP) surveillance is a screening method primarily used for the early detection of hepatocellular carcinoma (HCC) and other liver diseases in high-risk populations. The test measures the level of AFP, a tumor marker, in the blood. Regular follow-up examinations are crucial for monitoring patients with chronic liver disease.

## Why the Correct Answer is Right
The correct interval for follow-up examination under AFP surveillance is typically every 6 months. This frequency allows for the early detection of changes in AFP levels, which could indicate the development of HCC or other complications. The 6-month interval strikes a balance between being frequent enough to detect issues early and not so frequent that it becomes impractical or costly.

## Why Each Wrong Option is Incorrect
- **Option A:** A 1-month interval is too short and would likely result in unnecessary tests and increased healthcare costs without providing additional benefits in terms of early detection.
- **Option B:** A 3-month interval might seem reasonable but is less commonly recommended compared to 6 months. It could potentially delay diagnosis compared to a 6-month schedule.
- **Option D:** A 12-month interval is too long and could significantly delay the detection of HCC, potentially leading to more advanced disease at diagnosis.

## Clinical Pearl / High-Yield Fact
A key point to remember is that while AFP levels are a useful tool for screening, they are not definitive for diagnosing HCC. Patients with abnormal AFP levels or those with risk factors for HCC should undergo imaging studies (like ultrasound or MRI) for further evaluation. Additionally, it's crucial to note that not all HCCs produce AFP, making regular imaging and other diagnostic modalities essential.

## Correct Answer: C. 6 months.